1.
A Prospective Observational Study of Comparison, Safety, and Efficacy of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus in A Tertiary Care Hospital. AJPHS. 2022;12(4):2729-2738. doi:10.5530/ezagjy22